Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2008

Open Access 01-12-2008 | Research

Skin invasion and prognosis in node negative breast cancer: a retrospective study

Authors: Keiichiro Tada, Hidetomo Morizono, Kotaro Iijima, Yumi Miyagi, Seiichiro Nishimura, Masujiro Makita, Rie Horii, Futoshi Akiyama, Takuji Iwase

Published in: World Journal of Surgical Oncology | Issue 1/2008

Login to get access

Abstract

Background

The impact of skin invasion in node negative breast cancer is uncertain.

Methods

We determined the prognosis in 97 node negative breast cancer patients (case group) who had tumors with skin invasion. Then we compared these patients with 4500 node negative invasive breast cancer patients treated surgically in the same period.

Results

Patients with skin invasion tended to be older, had more invasive lobular carcinoma and larger tumor size, and were less likely to have breast conserving surgery than those in the control group. The 5-year disease-free survival rate in the case group was 94.0%. There was no significant difference in the 10-year disease-specific overall survival rates in terms of skin invasion in node negative patients (90.7% in the case group, 92.9% in the control group; p = 0.2032).

Conclusion

Results suggest that skin invasion has no impact on survival in node negative invasive breast cancer patients. The adjuvant regimens which the individual institute applies for node negative breast cancer should be used regardless of skin invasion.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sutherland CM, Mather FJ: Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes. Cancer. 1986, 57 (3): 622-629. 10.1002/1097-0142(19860201)57:3<622::AID-CNCR2820570338>3.0.CO;2-C.CrossRefPubMed Sutherland CM, Mather FJ: Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes. Cancer. 1986, 57 (3): 622-629. 10.1002/1097-0142(19860201)57:3<622::AID-CNCR2820570338>3.0.CO;2-C.CrossRefPubMed
2.
go back to reference Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989, 63 (1): 181-187. 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H.CrossRefPubMed Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989, 63 (1): 181-187. 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H.CrossRefPubMed
3.
go back to reference Perrone F, Carlomagno C, Lauria R, De Laurentiis M, Morabito A, Panico L, Pettinato G, Petrella G, Gallo C, Bianco AR, De Placido S: Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?. Eur J Cancer. 1996, 32A (1): 41-46. 10.1016/0959-8049(95)00442-4.CrossRefPubMed Perrone F, Carlomagno C, Lauria R, De Laurentiis M, Morabito A, Panico L, Pettinato G, Petrella G, Gallo C, Bianco AR, De Placido S: Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?. Eur J Cancer. 1996, 32A (1): 41-46. 10.1016/0959-8049(95)00442-4.CrossRefPubMed
4.
go back to reference UICC: TNM Classification of Malignant Tumours. Edited by: L.H.Sobin CW. 2002, New York , Wiley-Liss, 6th UICC: TNM Classification of Malignant Tumours. Edited by: L.H.Sobin CW. 2002, New York , Wiley-Liss, 6th
5.
go back to reference Iyer RV, Hanlon A, Fowble B, Freedman G, Nicolaou N, Anderson P, Hoffman J, Sigurdson E, Boraas M, Torosian M: Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined. Int J Radiat Oncol Biol Phys. 2000, 47 (5): 1177-1183.CrossRefPubMed Iyer RV, Hanlon A, Fowble B, Freedman G, Nicolaou N, Anderson P, Hoffman J, Sigurdson E, Boraas M, Torosian M: Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined. Int J Radiat Oncol Biol Phys. 2000, 47 (5): 1177-1183.CrossRefPubMed
6.
go back to reference Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P: Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996, 77 (1): 113-120. 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8.CrossRefPubMed Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P: Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996, 77 (1): 113-120. 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8.CrossRefPubMed
7.
go back to reference Fisher ER, Costantino J, Fisher B, Redmond C: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators. Cancer. 1993, 71 (6 Suppl): 2141-2150. 10.1002/1097-0142(19930315)71:6+<2141::AID-CNCR2820711603>3.0.CO;2-F.CrossRefPubMed Fisher ER, Costantino J, Fisher B, Redmond C: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators. Cancer. 1993, 71 (6 Suppl): 2141-2150. 10.1002/1097-0142(19930315)71:6+<2141::AID-CNCR2820711603>3.0.CO;2-F.CrossRefPubMed
8.
go back to reference Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ: Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005, 16 (10): 1569-1583. 10.1093/annonc/mdi326.CrossRefPubMed Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ: Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005, 16 (10): 1569-1583. 10.1093/annonc/mdi326.CrossRefPubMed
9.
go back to reference Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006, 355 (6): 560-569. 10.1056/NEJMoa052933.CrossRefPubMed Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006, 355 (6): 560-569. 10.1056/NEJMoa052933.CrossRefPubMed
10.
go back to reference Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Foekens JA, Beex LV, Sweep CG: Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer. Cancer Res. 2004, 64 (2): 659-664. 10.1158/0008-5472.CAN-03-1820.CrossRefPubMed Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Foekens JA, Beex LV, Sweep CG: Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer. Cancer Res. 2004, 64 (2): 659-664. 10.1158/0008-5472.CAN-03-1820.CrossRefPubMed
11.
go back to reference Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM: Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst. 2005, 97 (17): 1254-1261.CrossRefPubMed Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM: Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst. 2005, 97 (17): 1254-1261.CrossRefPubMed
12.
go back to reference Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS: Cyclin E and survival in patients with breast cancer. N Engl J Med. 2002, 347 (20): 1566-1575. 10.1056/NEJMoa021153.CrossRefPubMed Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS: Cyclin E and survival in patients with breast cancer. N Engl J Med. 2002, 347 (20): 1566-1575. 10.1056/NEJMoa021153.CrossRefPubMed
13.
go back to reference Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989, 244 (4905): 707-712. 10.1126/science.2470152.CrossRefPubMed Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989, 244 (4905): 707-712. 10.1126/science.2470152.CrossRefPubMed
14.
go back to reference Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999, 340 (19): 1455-1461. 10.1056/NEJM199905133401902.CrossRefPubMed Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999, 340 (19): 1455-1461. 10.1056/NEJM199905133401902.CrossRefPubMed
Metadata
Title
Skin invasion and prognosis in node negative breast cancer: a retrospective study
Authors
Keiichiro Tada
Hidetomo Morizono
Kotaro Iijima
Yumi Miyagi
Seiichiro Nishimura
Masujiro Makita
Rie Horii
Futoshi Akiyama
Takuji Iwase
Publication date
01-12-2008
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2008
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-6-10

Other articles of this Issue 1/2008

World Journal of Surgical Oncology 1/2008 Go to the issue